Showing results (301-310 of 2,338) with videos related to

Sort By:
Pageof 234
Clinical Lung Cancer|July 28, 2009
Skeletal disease contributes substantially to morbidity and mortality in patients with lung cancerVera Hirsh
Clinical Lung Cancer|July 28, 2009
Contralateral cervicomediastinal lymph node metastases from clinically occult adenocarcinoma of the lungMayumi Hoshikawa, Hideaki Mochizuki, Mio Saito, et al.
Clinical Lung Cancer|July 28, 2009
Development of the monoclonal antibody figitumumab, targeting the insulin-like growth factor-1 receptor, for the treatment of patients with non-small-cell lung cancerAntonio Gualberto, Daniel D Karp
Clinical Lung Cancer|July 28, 2009
Acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancers dependent on the epidermal growth factor receptor pathwayKim-Son H Nguyen, Susumu Kobayashi, Daniel B Costa
Clinical Lung Cancer|October 8, 2009
Quality indicators in cancer care: development and implementation for improved health outcomes in non-small-cell lung cancerInga T Lennes, Thomas J Lynch
Clinical Lung Cancer|September 3, 2011
Treatment of patients excluded from Eastern Cooperative Oncology Group 4599 and AVAiL studies: focus on brain metastasis and squamous histologyDaniel Morgensztern, Ramaswamy Govindan
Clinical Lung Cancer|September 3, 2011
Emerging safety data for bevacizumab in advanced non-small-cell lung cancerVera Hirsh
Clinical Lung Cancer|August 12, 2011
Induction pemetrexed and cisplatin followed by maintenance pemetrexed versus carboplatin plus paclitaxel plus bevacizumab followed by maintenance bevacizumab: a quality of life-oriented randomized phase III study in patients with advanced non-squamous non-small-cell lung cancer (ERACLE)Domenico Galetta, Salvatore Pisconti, Saverio Cinieri, et al.
Clinical Lung Cancer|January 31, 2012
Expressions of insulin-like growth factor receptor-1 and insulin-like growth factor binding protein 3 in advanced non-small-cell lung cancerYoung Hak Kim, Shinji Sumiyoshi, Seiji Hashimoto, et al.
Clinical Lung Cancer|July 15, 2011
Results from a single institution phase II trial of concurrent docetaxel/carboplatin/radiotherapy followed by surgical resection and consolidation docetaxel/carboplatin in stage III non-small-cell lung cancerMillie Das, Jessica S Donington, James Murphy, et al.
Pageof 234